Evidence map›Paper›PMID 37178492›Full record

SynthesisJournal of critical care2023

Intracranial hemorrhage in patients treated for SARS-CoV-2 with extracorporeal membrane oxygenation: A systematic review and meta-analysis.

Melissa Lannon, Taylor Duda, Alisha Greer, Mark Hewitt, Arjun Sharma, Amanda Martyniuk, Julian Owen, Faizan Amin, Sunjay Sharma

Open access · greenAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Journal of critical care, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Melissa LannonDivision of Neurosurgery, McMaster University, Hamilton, Ontario, Canada. Electronic address: melissa.lannon@medportal.ca.
Taylor DudaDivision of Neurosurgery, McMaster University, Hamilton, Ontario, Canada. Electronic address: taylor.duda@medportal.ca.
Alisha GreerDivision of Emergency Medicine, Department of Medicine, Division of Critical Care, McMaster University, Hamilton, Ontario, Canada. Electronic address: alisha.greer@medportal.ca.
Mark HewittDivision of Emergency Medicine, Department of Medicine, Division of Critical Care, McMaster University, Hamilton, Ontario, Canada. Electronic address: mark.hewitt@medportal.ca.
Arjun SharmaDepartment of Medicine, Division of Critical Care, McMaster University, Hamilton, Ontario, Canada. Electronic address: arjun.sharma@medportal.ca.
Amanda MartyniukDivision of Neurosurgery, McMaster University, Hamilton, Ontario, Canada. Electronic address: martynia@mcmaster.ca.
Julian OwenDivision of Emergency Medicine, Department of Medicine, Division of Critical Care, McMaster University, Hamilton, Ontario, Canada. Electronic address: julian.owen@medportal.ca.
Faizan AminDepartment of Medicine, Divisions of Critical Care and Cardiology, McMaster University, Hamilton, Ontario, Canada. Electronic address: faizan.amin@medportal.ca.
Sunjay SharmaDivision of Neurosurgery, McMaster University, Hamilton, Ontario, Canada. Electronic address: sharmasun@hhsc.ca.
McMaster University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExtracorporeal membrane oxygenation (ECMO) is routinely used in patients with severe respiratory failure and has been increasingly needed during the COVID-19 pandemic. In patients treated with ECMO, significant intracranial hemorrhage (ICH) risk exists due to circuit characteristics, anticoagulation, and disease characteristics. ICH risk may be substantially higher in COVID-19 patients than patients treated with ECMO for other indications.

methodsWe systematically reviewed current literature regarding ICH during ECMO treatment of COVID-19. We utilized Embase, MEDLINE, and Cochrane Library databases. Meta-analysis was performed for included comparative studies. Quality assessment was performed using MINORS criteria.

resultsA total of 54 studies with 4000 ECMO patients were included, all retrospective. Risk of bias was increased via MINORS score primarily due to retrospective designs. ICH was more likely in COVID-19 patients (RR 1.72, 95% CI 1.23, 2.42). Mortality among COVID patients on ECMO with ICH was 64.0%, compared with 41% in patients without ICH (RR1.9, 95% 1.44, 2.51).

conclusionThis study suggests increased hemorrhage rates in COVID-19 patients on ECMO compared to similar controls. Hemorrhage reduction strategies may include atypical anticoagulants, conservative anticoagulation strategies, or biotechnology advances in circuit design and surface coatings.

Indexed as

COVID-19Extracorporeal Membrane OxygenationAnticoagulantsHemorrhageHumansIntracranial HemorrhagesPandemicsRetrospective StudiesSARS-CoV-2AnticoagulantsAcute respiratory distress syndromeCOVID-19Extracorporeal membrane oxygenationIntracranial hemorrhage

Identifiers

PMID37178492
PMCPMC10173703
OpenAlexW4376155267

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.